4.01
price up icon2.56%   0.10
after-market Handel nachbörslich: 3.99 -0.02 -0.50%
loading

Vistagen Therapeutics Inc Aktie (VTGN) Neueste Nachrichten

pulisher
Oct 14, 2025

Tools to assess Vistagen Therapeutics Inc.’s risk profile2025 Macro Impact & Free Daily Entry Point Trade Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Will Vistagen Therapeutics Inc. stock gain from strong economyMarket Movement Recap & Expert Approved Momentum Ideas - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

What institutional flow reveals about Vistagen Therapeutics Inc.July 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

How to recover losses in Vistagen Therapeutics Inc. stockPortfolio Return Report & Free Technical Confirmation Trade Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Vistagen Therapeutics Inc. stock momentum explainedWeekly Loss Report & High Return Stock Watch Alerts - newser.com

Oct 13, 2025
pulisher
Oct 13, 2025

Combining machine learning predictions for Vistagen Therapeutics Inc.July 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com

Oct 13, 2025
pulisher
Oct 12, 2025

Applying Elliott Wave Theory to Vistagen Therapeutics Inc.Quarterly Trade Review & Weekly Market Pulse Updates - newser.com

Oct 12, 2025
pulisher
Oct 11, 2025

VistaGen Therapeutics’ (VTGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 09:33:10 - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Using Ichimoku Cloud for Vistagen Therapeutics Inc. technicalsExit Point & Intraday High Probability Setup Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Published on: 2025-10-10 04:25:39 - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

VistaGen Therapeutics (NASDAQ:VTGN) Given "Sell (D-)" Rating at Weiss Ratings - MarketBeat

Oct 09, 2025
pulisher
Oct 09, 2025

What MACD and RSI say about Vistagen Therapeutics Inc.July 2025 Fed Impact & Scalable Portfolio Growth Methods - newser.com

Oct 09, 2025
pulisher
Oct 09, 2025

We Think Vistagen Therapeutics (NASDAQ:VTGN) Needs To Drive Business Growth Carefully - Sahm

Oct 09, 2025
pulisher
Oct 09, 2025

Advanced analytics toolkit walkthrough for Vistagen Therapeutics Inc.July 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com

Oct 09, 2025
pulisher
Oct 07, 2025

High Stakes Ahead: Vistagen's Fasedienol Trials Could Make Or Break The Story - RTTNews

Oct 07, 2025
pulisher
Oct 06, 2025

Sector ETF performance correlation with Vistagen Therapeutics Inc.July 2025 Closing Moves & High Yield Stock Recommendations - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How moving averages guide Vistagen Therapeutics Inc. trading2025 Winners & Losers & High Accuracy Investment Entry Signals - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Detecting price anomalies in Vistagen Therapeutics Inc. with AIMarket Growth Review & Free Fast Gain Swing Trade Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Has Vistagen Therapeutics Inc. found a price floorJuly 2025 Action & Fast Entry and Exit Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Understanding Vistagen Therapeutics Inc.’s price movement2025 Top Decliners & Verified Stock Trade Ideas - newser.com

Oct 06, 2025
pulisher
Oct 05, 2025

Full technical analysis of Vistagen Therapeutics Inc. stockJuly 2025 Setups & Entry and Exit Point Strategies - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Vistagen Therapeutics Inc. stock daily chart insightsJuly 2025 PreEarnings & Real-Time Volume Surge Alerts - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

What’s the recovery path for long term holders of Vistagen Therapeutics Inc.Share Buyback & Verified Momentum Stock Watchlist - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

How high can Vistagen Therapeutics Inc. stock go2025 Market Sentiment & Free Safe Capital Growth Stock Tips - newser.com

Oct 03, 2025
pulisher
Oct 01, 2025

Vistagen Therapeutics Inc Stock Analysis and ForecastHigh Frequency Trading Trends & Access High Yield Alerts - earlytimes.in

Oct 01, 2025
pulisher
Oct 01, 2025

Acute Social Anxiety Disorder Market on Track for Major Expansion by 2034, According to DelveInsight | GlaxoSmithKline Plc, Viatris Inc, Johnson & Johnson, Novartis AG, Pfizer Inc, AstraZeneca Plc - Barchart.com

Oct 01, 2025
pulisher
Sep 30, 2025

Tools to monitor Vistagen Therapeutics Inc. recovery probabilityWatch List & Target Return Focused Picks - newser.com

Sep 30, 2025
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):